Table I.
First author | Year | Country/region | Racial descent | Source of controls | Case, n | Control, n | Genotype distribution | P-value HWEa | Pathology | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
Case, n | Control, n | |||||||||||||
|
|
|||||||||||||
GG | GA | AA | GG | GA | AA | |||||||||
Yu | 2003 | China | Asian | Population-based | 321 | 345 | 68 | 157 | 96 | 58 | 177 | 110 | 0.354 | ESCC |
Zhang | 2003 | China | Asian | Population-based | 120 | 183 | 11 | 74 | 35 | 38 | 102 | 43 | 0.118 | ESCC |
Casson | 2005 | Canada | Caucasian | Hospital-based | 56 | 95 | 12 | 27 | 17 | 35 | 52 | 8 | 0.063 | EA |
Geddert | 2005 | Germany | Caucasian | Hospital-based | 56 | 253 | 16 | 26 | 14 | 63 | 136 | 54 | 0.224 | EA |
Jain | 2007 | India | Asian | Hospital-based | 151 | 201 | 22 | 76 | 53 | 37 | 111 | 53 | 0.114 | Mixed |
Akbarib | 2009 | Iran | Caucasian | NA | 279 | 807 | 72 | 126 | 81 | 161 | 376 | 270 | 0.149 | ESCC |
Akbaric | 2009 | Iran | Caucasian | NA | 465 | 561 | 97 | 238 | 130 | 107 | 290 | 164 | 0.290 | ESCC |
Liu | 2010 | USA | Caucasian | Hospital-based | 299 | 450 | 79 | 154 | 66 | 128 | 215 | 107 | 0.369 | EA |
Kurmanov | 2010 | Kazakhstan | Caucasian | Population-based | 98 | 86 | 19 | 42 | 37 | 24 | 46 | 16 | 0.463 | ESCC |
Hussain | 2011 | India | Asian | Population-based | 151 | 151 | 20 | 99 | 32 | 56 | 72 | 23 | 0.986 | ESCC |
Djansugurova | 2013 | Kazakhstan | Caucasian | Healthy-based | 115 | 100 | 22 | 49 | 44 | 28 | 54 | 18 | 0.363 | ESCC |
HWE in controls;
study 1;
study 2.
HWE, Hardy-Weinberg equilibrium; ESCC, esophageal squamous cell carcinoma; EA, esophageal adenocarcinoma; Mixed, ESCC and EA; NA, not available.